Production of a Vaccine against Coronavirus infection is planned to begin by the end of summer, Alexander Ginzburg, Director of the N. F. Gamalei research Institute of epidemiology and Microbiology of the Ministry of health of the Russian Federation, told media on May 23.
“We are given such deadlines, based on what we still have to do in the conditions of the pandemic, by the end of the summer, so that we will try to enter production already. Unfortunately, production will not immediately allow a large number of the population of our country to be immunized, but now health organizers are making unprecedented efforts and actions to move as quickly as possible to scale it when the Vaccine is registered,” he said.
A day earlier, Alexander Gorelov, Deputy Director of the Rospotrebnadzor research Institute, said that the first results of a human study of the coronavirus vaccine will appear in Russia in early July. According to him, the safety of the vaccine is formed in several stages, including during long-term tests on various animals, and only then on humans.
Earlier on Friday, Director of national research centre of epidemiology and Microbiology them. N. F. Gamalei, Ministry of health of Ukraine (NICAM) academician Alexander Gintsburg said about the trial of a Vaccine against Coronavirus on the staff.
Among the testers are developers, organizers of preclinical research and technologists of the center. According to Ginzburg, the vaccine based on adenovirus DNA, which has the SARS-CoV-2 Coronavirus gene embedded in it, did not produce side effects.
Virologist, doctor of medical Sciences Anatoly Alstein assessed this vaccine, calling it promising.